Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-27032026-271323
EXTRAORDINARY
PART II—Section 3—Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 1525]
NEW DELHI, WEDNESDAY, MARCH 25, 2026/ CHAITRA 4, 1948
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 25th March, 2026
S.O. 1590(E). — In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control)
Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the
Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority
(hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price,
exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column
(2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the
corresponding entries in columns (3), (4) and (5) thereof;
TABLE
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| Sl. | Name of the Formulation / | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| No. | Brand Name | | | | |
+=====+=============================================+===================================================================================================================================================================================================+===========+=================================================================+====================
| (1) | (2) | (3) | (4) | (5) | (6) |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 1 | Aceclofenac, Paracetamol and | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg | 1 Tablet | M/s Innova Captab Ltd./ M/s. Dr. Reddys Laboratories Ltd. | 4.95 |
| | Chlorzoxazone Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 2 | Alpha Lipoic Acid, Pyridoxine | Each film coated tablet contains: Alpha Lipoic Acid coated Eq. to Alpha Lipoic Acid IP 100 mg Pyridoxine Hydrochloride IP 3 mg Mecobalamin IP 1500 mcgFolic Acid IP 1.5 mg Vitamin D3 Stabilized Eq. to | 1 Tablet | M/s Windlas Biotech Limited/ M/s Alkem Laboratories Ltd. | 16.62 |
| | Hydrochloride, Mecobalamin, Folic Acid and | Vitamin D3 IP 1000 IU | | | |
| | Vitamin D3 Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 3 | Atorvastatin Calcium and Clopidogrel | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eq. to Atorvastatin (as pellets) 10 mg Clopidogrel Bisulphate IP Eq. to Clopidogrel (as pellets) 75 mg | 1 Capsule | M/s Synokem Pharmaceuticals Limited/ M/s Alkem Wellness Limited | 15.20 |
| | Capsules | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 4 | Bilastine and Montelukast Tablets | Each film coated bilayered tablet contains: Bilastine IP 40 mg Montelukast Sodium IP Eq. to Montelukast 10 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Hetero Healthcare Ltd. | 16.67 |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 5 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated Bi-layered tablet contains: Bisoprolol Fumarate IP 2.5mg Telmisartan IP 40 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Indchemie Health | 10.68 |
| | | | | Specialities Pvt. Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 6 | Calcium, Cholecalciferol and Folic Acid | Each Film Coated Tablet Contains: Calcium Citrate Maleate IP Eq. to Elemental Calcium 250 mg Cholecalciferol (Vitamin D3) IP 100 IU Folic Acid IP 50 mcg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s J.B Chemicals & | 11.86 |
| | Tablets | | | Pharmaceuticals Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 7 | Cefuroxime Axetil and Potassium | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg | 1 Tablet | M/s Alps Communication Pvt. Ltd./ M/s Jagsonpal | 63.94 |
| | Clavulanate Tablets | | | Pharmaceuticals Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 8 | Cholecalciferol (Vitamin D3) Drops | Each ml contains: Cholecalciferol IP 800 IU (In a nano droplet form) | 1 ML | M/s Tirupati Medicare Ltd./ M/s Galpha Laboratories Ltd. | 6.09 |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 9 | Clopidogrel, Aspirin and Atorvastatin | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eq. to Atorvastatin 40 mg (as two film coated tablet) Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg Aspirin IP 75mg (As Gastro- | 1 Capsule | M/s Safetab Life Science/ M/s Corona Remedies Pvt. Ltd. | 13.66 |
| | Capsules | resistant tablet) | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 10 | Dried Factor VIII Fraction/ Lyophilized | Each vial contains: Factor VIII IP (1000 IU) - Protein Content IP (≤ 80 g/L) - Sodium Chloride IP (≤ 250 mM) Sodium Citrate IP (≤ 10 mM) - Calcium Chloride IP (≤ 1 mM) - Mannitol IP (≤7.6% W/V) | 1 Vial | M/s Reliance Life Sciences Pvt. Ltd. | 14666.35 |
| | | - Glycine IP (≤ 300 mM) Lycine HCL BP (≤ 25 mM) - Sucrose IP (≤ 1% W/V) Sodium ion content IP (≤ 200 mM/L) - Fibrinogen content (of total protein) (≤80%) | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 11 | Empagliflozin, Linagliptin and Metformin | Each film coated bilayer tablet contains: Empagliflozin 25 mg Linagliptin 5 mg Metformin Hydrochloride (As Extended Release) IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Unison Pharmaceuticals Pvt. Ltd. | 14.05 |
| | Hydrochloride Extended-Release Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 12 | Empagliflozin, Sitagliptin and Metformin | Each film coated bilayer tablet contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride (As Extended Release) IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt. Ltd. | 16.12 |
| | Hydrochloride Extended-Release Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 13 | Empagliflozin, Sitagliptin and Metformin | Each film coated bilayer tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride (As Extended Release) IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt. Ltd. | 22.77 |
| | Hydrochloride Extended-Release Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 14 | Magnesium and Vitamin D3 Tablets | Each film coated tablet contains: Magnesium bisglycinate Eq. to elemental Magnesium 250 mg Vitamin D3 IP 1000 IU | 1 Tablet | M/s Alkem Health Science (A Unit of Alkem Laboratories Ltd)/ M/s | 21.66 |
| | | | | Alkem Laboratories Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 15 | Olmesartan Medoxomil, Amlodipine and | Each film coated tablet contains: Olmesartan Medoxomil IP 20 mg Amlodipine Besilate IP Eq. to Amlodipine 5 mg Hydrochlorothiazide IP 12.5 mg | 1 Tablet | M/s Windlas Biotech Limited/ M/s Alkem Wellness Limited | 16.74 |
| | Hydrochlorothiazide Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 16 | Olmesartan Medoxomil, Amlodipine and | Each film coated tablet contains: Olmesartan Medoxomil IP 40 mg Amlodipine Besilate IP Eq. to Amlodipine 5 mg Hydrochlorothiazide IP 12.5 mg | 1 Tablet | M/s Windlas Biotech Limited/ M/s Alkem Wellness Limited | 21.29 |
| | Hydrochlorothiazide Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 17 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg | 1 ML | M/s Mistair Health & Hygiene Pvt. Ltd./ M/s Zorvia Healthcare Ltd. | 0.93 |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 18 | Sitagliptin, Glimepiride and Metformin | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Unison Pharmaceuticals Pvt. Ltd. | 10.39 |
| | Hydrochloride Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 19 | Sitagliptin, Glimepiride and Metformin | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Unison Pharmaceuticals Pvt. Ltd. | 11.90 |
| | Hydrochloride Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 20 | Tacrolimus Ointment | Composition: Tacrolimus IP 0.03%w/w | 1 GM | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies | 21.44 |
| | | | | Pharmaceuticals Pvt. Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 21 | Telmisartan, Cilnidipine and Metoprolol | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg (As extended-release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd. | 14.49 |
| | Succinate (ER) Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 22 | Telmisartan, Cilnidipine and Metoprolol | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended-release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd. | 11.77 |
| | Succinate (ER) Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 23 | Vitamin D3 (Cholecalciferol) Drops | Each ml contains: Vitamin D3 Cholecalciferol) IP 800 IU | 1 ML | M/s Tirupati Medicare Ltd./ M/s Zorvia Healthcare Limited | 6.09 |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 24 | Paracetamol, Caffeine Anhydrous, | Each uncoated tablet contains: Paracetamol IP 650 mg Caffeine Anhydrous IP 30 mg Phenylephrine Hcl IP 10 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s Dallas Drugs Pvt. Ltd./ M/s Centaur Pharmaceuticals Pvt. Ltd. | 7.50 |
| | Phenylephrine Hcl and Chlorpheniramine | | | | |
| | Maleate Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 25 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 120.62 |
| | Acetate Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 26 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Dr. Reddys | 120.62 |
| | Acetate Tablets | | | Laboratories Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 27 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent | 120.62 |
| | Acetate Tablets | | | Pharmaceuticals Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 28 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s La Renon | 120.62 |
| | Acetate Tablets | | | Healthcare Pvt. Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 29 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Eris Lifesciences Ltd. | 120.62 |
| | Acetate Tablets | | | | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 30 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Akumentis | 120.62 |
| | Acetate Tablets | | | Healthcare Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
| 31 | Relugolix, Estradiol and Norethindrone | Each Film Coated Tablet contains: Relugolix 40 mg Estradiol (As Hemihydrate) USP eq. to Anhydrous Estradiol 1 mg Norethindrone Acetate USP 0.5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Aurobindo | 120.62 |
| | Acetate Tablets | | | Pharma Ltd. | |
+-----+---------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+-----------------------------------------------------------------+--------------------+
Notes:
(a) The manufacturer of above-mentioned formulations i.e., “new drug" under paragraph 2(1)(u) of the DPCO,
2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the
Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in
accordance with the retail price specified in column (6) of the above table as per provisions contained in
paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification
as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller
and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price
list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business
in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned
above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under
DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt.
under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e.
the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing
companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification
and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit
the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the
Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with
the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in
Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength
for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5)
thereof, if any, issued prior to this notification, stand(s) superseded.
[PN/276/144/2026/F/ F. No. 8(144)/2026/D.P./NPPA-Div.-II ]
BHIVA RAM YADAV, Assistant Director
Login to read full text